Ceza Formulations Private Limited

Ceza Formulations Private Limited - pharma in Indore, Madhya Pradesh, India. FY 2026 financials & compliance.
CIN U24232MP1999PTC013421 Incorporated 26 March 1999 ROC Gwalior HQ Indore, Madhya Pradesh, India
Active Private Limited Company pharma MSME · Micro
Revenue · FY 2024
₹3.6 Cr
▲ 50% YoY
Net profit · FY 2024
₹50,770
Net margin 0.1%
EBITDA · FY 2024
₹36.56 Lakh
EBITDA margin 10.1%
Authorised capital
₹15 Lakh
Registered with MCA
Paid-up capital
₹15 Lakh
Issued & subscribed
Open charges
₹78 Lakh
Satisfied ₹1.03 Cr
Company age
27 yrs
Est. 1999
Employees · EPFO
8
Provident fund records

About Ceza Formulations Private Limited

Data last updated:

Ceza Formulations Private Limited is a private limited company based in Indore, Madhya Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 26 March 1999 and has been in existence for over 27 years.

The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U24232MP1999PTC013421. Its GSTIN is 23AACCC1848B1ZA (Madhya Pradesh). The company holds 2 GST registrations, of which 1 is active.

The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹15 Lakh. It is led by directors including Narendra Kumar Dalawat and Mimoh Paliwal.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 236 Sectore E. Sanwer Road Industrial Area, Indore, Madhya Pradesh, India – 452001.

As per the financials filed for FY 2024, the company reported a revenue of ₹3.6 Cr, a growth of 50% compared to the previous year. For the same year it recorded a net profit of ₹50,770 (net margin 0.1%) and EBITDA of ₹36.56 Lakh (EBITDA margin 10.1%). Revenue has declined at a compounded annual rate (CAGR) of 25% over three years and 3% over five years.

The company has about 8 employees on its provident fund (EPFO) records.

As per MCA filings, the company has open charges of ₹78 Lakh and satisfied charges of ₹1.03 Cr on record.

Ceza Formulations Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MP-23-0067193). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website ceza-formulations-pl.business.site.

Company details

CIN U24232MP1999PTC013421
Registration Number 013421
Incorporation Date 26 March 1999
ROC Gwalior
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-MP-23-0067193

Recognitions & Rankings of Ceza Formulations

MSME (Udyam registered) Ministry of MSME
Category
Micro (2024-25)
Udyam number
UDYAM-MP-23-0067193

Contact details

Ceza Formulations Private Limited's registered office is in Indore, Madhya Pradesh. Its website is ceza-formulations-pl.business.site. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    236 Sectore E. Sanwer Road Industrial Area, Indore, Madhya Pradesh, India – 452001
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Ceza Formulations Private Limited, buy the company report.

Comprehensive company report
Ceza Formulations Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Ceza Formulations is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Ceza Formulations Private Limited, buy the company report.

Financials of Ceza Formulations Private Limited

FY 2025 filings available

Ceza Formulations Private Limited reported revenue of ₹3.6 Cr (up 50% YoY) for FY 2024.

Revenue · FY 2024
₹3.6 Cr ▲ 50%
Net profit · FY 2024
₹50,770 margin 0.1%
EBITDA · FY 2024
₹36.56 Lakh margin 10.1%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 50%
3 years · compounded
▲ 25%
5 years · compounded
▼ 3%
EBITDA CAGR growth
1 year
▲ 130%
3 years · compounded
▲ 11%
5 years · compounded
▼ 5%

Revenue rose 50% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 3%. EBITDA rose 130% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹36.56 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹50,770
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profitability
EBITDA Margin10.1%
Net Profit Margin0.1%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Ceza Formulations Private Limited, buy the company report.

Board of directors of Ceza Formulations Private Limited

Ceza Formulations has 4 current directors and 8 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Narendra Kumar DalawatDirector11 Jul 201610 Years 4 MonthsCurrent
Mimoh PaliwalDirector10 Nov 201412 Years 0 MonthsCurrent
Krishnakant MundraDirector10 Nov 201412 Years 0 MonthsCurrent
Anil Kumar VyasDirector13 Dec 201411 Years 11 MonthsCurrent

Peer comparison

Ceza Formulations Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Baxil Pharma Private Limited₹3.62 Cr (FY 2025)-47.0%Delhi, India
Captalo Pharma Private Limited₹3.61 Cr (FY 2024)304.0%Ahmedabad, Gujarat, India
Ceza Formulations Private Limitedthis company₹3.6 Cr (FY 2024)₹50,7700.1%50.0%8Indore, Madhya Pradesh, India
TPS Laboratories Pvt Ltd₹3.59 Cr (FY 2017)-16.0%Hyderabad, Telangana, India
Primodia Chemicals and Pharmaceuticals Private Limited₹3.59 Cr (FY 2024)18.0%Hyderabad, Telangana, India

To see the full peer comparison of Ceza Formulations Private Limited, buy the company report.

Auditor

Ceza Formulations Private Limited is audited by Nahata Mahajan & Co. for the financial year 2023.

Auditor firmFinancial yearFirm registration number
Nahata Mahajan & Co.FY 2023009739C

Shareholding

The shareholding of Ceza Formulations Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2021FY 2019FY 2018FY 2017
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Ceza Formulations Private Limited, buy the company report.

Charges & borrowings

Open charges
₹78 Lakh
Satisfied charges
₹1.03 Cr
Breakdown by lending institutions
Others₹0.78 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
17 Dec 2018100234068Others₹78 LakhOpen
24 Oct 2016100060752Others₹92.5 LakhSatisfied
25 Apr 200190205691State Bank of India₹5 LakhSatisfied
25 Apr 200190208854State Bank of Indore₹5 LakhSatisfied

To see the full charge records of Ceza Formulations Private Limited, buy the company report.

Total charge records: 4 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Ceza Formulations Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Ceza Formulations Private Limited has a workforce of 8 employees on its EPFO records as of Dec 2025, across 1 active EPFO establishment.

Employee count
8
Active EPFO establishments
1

Headcount by financial year

Financial yearEmployees (EPFO)
FY 2025-268
FY 2024-25
FY 2023-24
FY 2022-23
FY 2021-22
FY 2020-21
FY 2019-20
FY 2018-19
FY 2017-18
FY 2016-17

To see the full employee and EPFO history of Ceza Formulations Private Limited, buy the company report.

GST

Ceza Formulations has 2 GST registrations: 1 active and 1 cancelled or inactive.

Total GSTINs
2
Active
1
Cancelled / inactive
1
GSTINStateStatusRegistered on
23AACCC1848B1ZAMadhya PradeshActive01 Jul 2017

To see the full GST registrations and return filing status of Ceza Formulations Private Limited, buy the company report.

Recent activity

Ceza Formulations Private Limited has 12 board changes on record since 2011: 4 appointments and 8 cessations. The latest: Narendra Kumar Dalawat ceased to be Additional Director on 30 Sep 2016.

AGM
Ceza Formulations Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Ceza Formulations Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Gwalior.
Charges
A charge with Others of Rs. 78.00 Lakh registered on 17 Dec 2018 with Charge ID 100234068 was modified on 06 Mar 2019.
Charges
A charge registered on 24 Oct 2016 via Charge ID 100060752 with Others was fully satisfied on 05 Feb 2019.
Charges
A charge with Others amounted to Rs. 78.00 Lakh with Charge ID 100234068 was registered on 17 Dec 2018.
Charges
A charge with Others amounted to Rs. 92.50 Lakh with Charge ID 100060752 was registered on 24 Oct 2016.
Ceased
Narendra Kumar Dalawat ceased to be Additional Director.
Ceased
Alex Charles Fernandes ceased to be Director.
Appointed
Narendra Kumar Dalawat was appointed as Director.
Ceased
Anil Kumar Vyas ceased to be Additional Director.
Ceased
Krishnakant Mundra ceased to be Additional Director.
Ceased
Mimoh Paliwal ceased to be Additional Director.

13 earlier events are in the company report.

Frequently asked questions

Ceza Formulations is an active private limited company based in Indore, Madhya Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 26 March 1999 (27+ years old) and is registered under CIN U24232MP1999PTC013421.

Ceza Formulations has 4 current directors:

The latest financial statements of Ceza Formulations on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Ceza Formulations is 23AACCC1848B1ZA, registered in Madhya Pradesh. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.

The CIN (Corporate Identification Number) of Ceza Formulations is U24232MP1999PTC013421. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Ceza Formulations was incorporated on 26 March 1999, making it 27+ years old. It is registered with the Registrar of Companies, Gwalior.

The peers of Ceza Formulations by revenue are Baxil Pharma Private Limited, Captalo Pharma Private Limited, TPS Laboratories Pvt Ltd, Primodia Chemicals and Pharmaceuticals Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Narendra Kumar Dalawat ceased to be Additional Director on 30 Sep 2016. Alex Charles Fernandes ceased to be Director on 18 Aug 2016. Narendra Kumar Dalawat was appointed as Director on 11 Jul 2016. Ceza Formulations has 12 board changes on record in total.

Yes, Ceza Formulations is registered as a micro enterprise under Udyam registration (number: UDYAM-MP-23-0067193).

Ceza Formulations can be reached through the website ceza-formulations-pl.business.site. Its registered office is in Indore, Madhya Pradesh, India.

The registered office of Ceza Formulations is at 236 Sectore E. Sanwer Road Industrial Area, Indore, Madhya Pradesh, India – 452001.